Literature DB >> 19263201

Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation.

Karuna Chilukuri1, Charles A Henrikson, Darshan Dalal, Daniel Scherr, Edwin C MacPherson, Alan Cheng, David Spragg, Saman Nazarian, Sunil Sinha, Ronald Berger, Joseph E Marine, Hugh Calkins.   

Abstract

BACKGROUND: Aggressive anticoagulation with heparin to maintain an activated clotting time (ACT) >300 s is required during catheter ablation of atrial fibrillation (AF) to reduce the risk of systemic thromboembolism. The purpose of this study is to describe the incidence and outcome of protamine reactions and analyze the risk factors in patients undergoing catheter ablation of AF.
METHODS: The patient population included 242 consecutive patients (193 men, age 57.6 +/- 10.8 years) with drug refractory AF who underwent catheter ablation and received protamine immediately following catheter ablation to reverse the effects of heparin. Fifty eight of these patients had prior exposure to protamine.
RESULTS: Three of the 242 patients in our study developed an adverse reaction to protamine (1.2%). Although each of the three protamine reaction presented in a dramatic fashion with profound hypotension, all three patients responded to medical treatment and did not experience clinical sequelae. Age, gender, type of AF, number of ablations, prior exposure, diabetes mellitus, and ejection fraction did not predict the occurrence of these reactions.
CONCLUSION: This study reports, for the first time, the incidence and outcomes of protamine reaction in patients undergoing catheter ablation of AF. The results of this study reveal that protamine reactions present in a dramatic fashion often with profound hypotension. Although the incidence of protamine reactions in this setting is low (1.2%), they do occur. Electrophysiologists who use protamine need to be aware of this reaction and the appropriate therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19263201     DOI: 10.1007/s10840-009-9364-0

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  18 in total

1.  The diagnosis and management of anaphylaxis: an updated practice parameter.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

Review 2.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

Review 3.  Allergy to protamine sulfate.

Authors:  R Porsche; Z R Brenner
Journal:  Heart Lung       Date:  1999 Nov-Dec       Impact factor: 2.210

4.  Adverse reactions to protamine sulfate during cardiac surgery in diabetic and non-diabetic patients.

Authors:  G M Gottschlich; G P Gravlee; J W Georgitis
Journal:  Ann Allergy       Date:  1988-10

5.  Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization.

Authors:  W J Stewart; S M McSweeney; M A Kellett; D P Faxon; T J Ryan
Journal:  Circulation       Date:  1984-11       Impact factor: 29.690

6.  Shock of anaphylactoid type induced by protamine: a continuous cardiorespiratory record.

Authors:  L Nordström; R Fletcher; K Pavek
Journal:  Acta Anaesthesiol Scand       Date:  1978       Impact factor: 2.105

7.  Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation.

Authors:  Aamir Cheema; Jun Dong; Darshan Dalal; Joseph E Marine; Charles A Henrikson; David Spragg; Alan Cheng; Saman Nazarian; Kenneth Bilchick; Sunil Sinha; Daniel Scherr; Ibrahim Almasry; Henry Halperin; Ronald Berger; Hugh Calkins
Journal:  J Cardiovasc Electrophysiol       Date:  2007-04

8.  Evaluation of patients at risk for protamine reactions.

Authors:  J H Levy; I M Schwieger; J R Zaidan; B A Faraj; W S Weintraub
Journal:  J Thorac Cardiovasc Surg       Date:  1989-08       Impact factor: 5.209

Review 9.  Protamine: a review of its toxicity.

Authors:  J C Horrow
Journal:  Anesth Analg       Date:  1985-03       Impact factor: 5.108

10.  The use of protamine after radiofrequency catheter ablation: a pilot study.

Authors:  Aarti A Patel; Christopher A Clyne; Nickole N Henyan; C Michael White; Bryan F Zembrowski; Magdy Migeed; Ravi Yarlagadda; Jeffrey Kluger; Craig I Coleman
Journal:  J Interv Card Electrophysiol       Date:  2007-02-23       Impact factor: 1.759

View more
  15 in total

1.  [Pre-interventional, peri-interventional and post-interventional anticoagulation in the setting of catheter ablation for atrial fibrillation : current practice and practical approach].

Authors:  M Antz; S Willems; B A Hoffmann
Journal:  Herz       Date:  2015-02       Impact factor: 1.443

2.  Safety and efficacy outcomes of protamine administration for heparin reversal following cryoballoon-based pulmonary vein isolation.

Authors:  Kadri Murat Gurses; Duygu Kocyigit; Muhammed Ulvi Yalcin; Banu Evranos; Hikmet Yorgun; Mehmet Levent Sahiner; Ergun Baris Kaya; Mehmet Ali Oto; Necla Ozer; Kudret Aytemir
Journal:  J Interv Card Electrophysiol       Date:  2015-02-28       Impact factor: 1.900

3.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

4.  Use of vascular closure device is safe and effective in electrophysiological procedures.

Authors:  Ilir Maraj; Adam S Budzikowski; Waleed Ali; Crisitina A Mitre; John Kassotis
Journal:  J Interv Card Electrophysiol       Date:  2015-04-29       Impact factor: 1.900

5.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

Review 6.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

Review 7.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Europace       Date:  2018-01-01       Impact factor: 5.214

8.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  J Interv Card Electrophysiol       Date:  2017-10       Impact factor: 1.900

9.  Periprocedural outcomes of prophylactic protamine administration for reversal of heparin after cryoballoon ablation of atrial fibrillation.

Authors:  Giulio Conte; Carlo de Asmundis; Giannis Baltogiannis; Giacomo Di Giovanni; Giuseppe Ciconte; Juan Sieira; Yukio Saitoh; Kristel Wauters; Giacomo Mugnai; Justo Julià; Ghazala Irfan; Moises Levinstein; Hugo Enrique Cotino-Moreno; Gian-Battista Chierchia; Pedro Brugada
Journal:  J Interv Card Electrophysiol       Date:  2014-06-18       Impact factor: 1.900

10.  Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.

Authors:  Gerard Loughlin; Tomás Datino Romaniega; Javier Garcia-Fernandez; David Calvo; Ricardo Salgado; Andres Alonso; Xin Li; Angel Arenal; Esteban González-Torrecilla; Felipe Atienza; Francisco Fernández-Avilés
Journal:  J Interv Card Electrophysiol       Date:  2016-01-06       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.